Royal Bank of Canada »

Tempest Therapeutics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Tempest Therapeutics (TPST) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Tempest Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tempest Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tempest Therapeutics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2026-03-31 $0 27 0.00

More positions owned by Royal Bank of Canada

Apple (AAPL)
NVIDIA Corporation (NVDA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Rbc Cad (RY)
Toronto Dominion Bk Ont Com New (TD)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Bank Of Montreal Cadcom (BMO)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Cibc Cad (CM)
Canadian Natural Resources (CNQ)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Royal Bank of Canada

Top funds holding Tempest Therapeutics

Vanguard Capital Management
Vanguard Group
Geode Capital Management
Vanguard Fiduciary Trust
BlackRock
FMR
Sabby Management
Northern Trust
Dimensional Fund Advisors
UBS Group
Tower Research Capital
Morgan Stanley
Advisor Group Holdings
Atlantic Trust
Federation des caisses Desjardins du Quebec

View all funds holding Tempest Therapeutics